-
Five-drug combination for ultra-high-risk bone marrow cancer identified
PharmaTimes
December 14, 2021
A team at The Institute of Cancer Research (ICR), London and the Clinical Trials Research Unit (CTRU) at the University of Leeds adopted a new high-speed trial methodology.
-
50 Years of Progress in Treating Patients with Cancer
FDA
December 13, 2021
By Richard?Pazdur, MD,?Director, Oncology Center of Excellence (OCE)?and Acting Director, Office of Oncologic Diseases (OOD)
-
LianBio Provides Corporate Update and Reports?Third?Quarter 2021 Financial Results
PhamaSources.com
December 10, 2021
LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today provided a corporate update and reported financial results for the third quarter ended September 30, 2021.
-
Updated NCCN Distress Thermometer and Problem List Helps People Cope with Cancer Symptoms and Treatment
prnasia
December 07, 2021
The National Comprehensive Cancer Network (NCCN?)—a nonprofit alliance of leading cancer centers—announces updates to its widely-used resource for enabling discussion and treatment of distress as part of routine care...
-
GSK unveils Target the Future, a global, multi-year programme to help address key challenges affecting the multiple myeloma community
WorldPharmaNews
December 02, 2021
GlaxoSmithKline (GSK) plc today launched Target the Future, an international, multi-year initiative dedicated to advancing innovation and addressing key needs in the multiple myeloma community. The programme will provide education on progress in ...
-
Late cancer diagnoses rise as NHS struggles with COVID-19
PharmaTimes
December 01, 2021
Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic...
-
COVID-19 Booster Shot Helps Vast Majority of Cancer Patients
prnewswire
November 18, 2021
Most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 were helped by a third vaccine dose, according to a new study by investigators at the Montefiore Einstein Cancer Center...
-
Trillium Therapeutics Receives Final Court Order Approving Arrangement
FirstWordPharma
October 29, 2021
Trillium Therapeutics Inc. ("Trillium" or the "Company") (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology? company developing innovative therapies for the treatment of cancer, is pleased to announce that...
-
NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes
prnasia
October 25, 2021
The National Comprehensive Cancer Network? (NCCN?)—an alliance of leading cancer centers in the United States—today announced the publication of new NCCN Guidelines? for Cervical Cancer: Poland Edition.
-
World Liquid Biopsy Markets Report 2021: Liquid Biopsy Progress Delayed by COVID Pandemic but Huge Cancer Screening Opportunity Still Looms - Forecast to 2025
prnewswire
October 13, 2021
The "Liquid Biopsy Markets by Cancer Type and by Usage Type with Impact of COVID-19 Pandemic. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2021-2025" report...